Codiak has mastered the challenges of industrial-scale exosome production. We have developed proprietary methods to engineer, produce and purify exosomes at the scale and quality necessary to support regulatory scrutiny. This removes one of the key bottlenecks to industrializing exosomes and allows us to create a new wave of innovative drugs and substantial value.